Evaluating the efficacy of intranasal oxytocin on pain and function among individuals who experience chronic pain: a protocol for a multisite, placebo-controlled, blinded, sequential, within-subjects crossover trial

• David Flusk,
• Lynn Cooper,
• Maryam Nasr-Esfahani,
• Aaron MacInnes,
• Yanqing Yi,
• Joshua A. Rash,
• Tavis S. Campbell,
• Anastasia A. Mekhael,
• Patricia A. Poulin

Affiliations

David Flusk

Anesthesia and Pain Medicine, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada

Lynn Cooper

Canadian Injured Workers Alliance, Thunder Bay, Ontario, Canada

Maryam Nasr-Esfahani

Department of Anesthesiology, Perioperative and Pain Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Aaron MacInnes

Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Yanqing Yi

Community Health and Humanities, Faculty of Medicine, Memorial University of Newfoundland, St. John`s, Newfoundland, Canada

Joshua A. Rash

Department of Psychology, Faculty of Science, Memorial University of Newfoundland, St. John’s, Newfoundland, Canada

Tavis S. Campbell

Department of Psychology, Faculty of Arts, University of Calgary, Calgary, Alberta, Canada

Anastasia A. Mekhael

Department of Psychology, Faculty of Science, Memorial University of Newfoundland, St. John’s, Newfoundland, Canada

Patricia A. Poulin

The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada